Regulatory Advisory

  • Market Entry: Representing Assembly BioSciences and Biogen with respect to inception of its China business and new production launch in China market.
  • R&D/Clinical Trial: Representing C-Stone Pharmaceuticals, AnHeart Therapeutics, Visen Pharmaceuticals, Laekna Therapeutics, Biogen, Astellas Pharma and Assembly BioSciences, regarding their research and development projects and clinical trials.
  • Product and Commercial Activities: Representing Novartis, Roche Pharmaceuticals, AstraZeneca, C-Stone Pharmaceuticals, Smith Nephew, Biogen, Bayer Healthcare, Carl Zeiss and a number of other life science companies, in regulatory issues arising from daily business, including without limitation market authorization, product distributions, PAP/PSP, PBM, product promotions, and interactions with NGO.